Venetoclax: a promising repurposed drug against SARS-CoV-2 main protease

References

• Vuong, W., Khan, M. B., Fischer, C., Arutyunova, E., Lamer, T., Shields, J., Saffran, H. A., McKay, R. T., van Belkum, M. J., Joyce, M. A., Young, H. S., Tyrrell, D. L., Vederas, J. C., & Lemieux, M. J. (2020). Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication. Nature Communications, 11(1), 4282–4290. https://doi.org/10.1038/s41467-020-18096-2
   Web of Science ®Google Scholar
• Akaji, K., & Konno, H. (2020). Design and evaluation of anti-SARS-coronavirus agents based on molecular interactions with the viral protease. Molecules (Basel, Switzerland), 25(17), 3920-3939. https://doi.org/10.3390/molecules25173920
   Google Scholar
• Anand, K., Palm, G. J., Mesters, J. R., Siddell, S. G., Ziebuhr, J., & Hilgenfeld, R. (2002). Structure of coronavirus main proteinase reveals combination of a chymotrypsin fold with an extra alpha-helical domain. The EMBO Journal, 21(13), 3213–3224. https://doi.org/10.1093/emboj/cdf327
   PubMed Web of Science ®Google Scholar
• Banerjee, K., Padmavathi, G., Bhattacherjee, D., Saha, S., Kunnumakkara, A. B., & Bhabak, K. P. (2018). Potent anti-proliferative activities of organochalcogenocyanates towards breast cancer. Org Biomol Chem, 16(45), 8769–8782. https://doi.org/10.1039/c8ob01891j
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J. C., Postma, J. P. M., Van Gunsteren, W. F., Dinola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118
   Web of Science ®Google Scholar
• Bhabak, K. P., & Mugesh, G. (2007). Synthesis, characterization, and antioxidant activity of some ebselen analogues. Chemistry–A European Journal, 13(16), 4594–4601. https://doi.org/10.1002/chem.200601584
   PubMed Web of Science ®Google Scholar
• Bhattacherjee, D., Basu, C., Bhardwaj, Q., Mal, S., Sahu, S., Sur, R., & Bhabak, K. P. (2017). Design, synthesis and anti-cancer activities of benzyl analogues of garlic-derived diallyl disulfide (DADS) and the corresponding diselenides. ChemistrySelect, 2(24), 7399–7406. https://doi.org/10.1002/slct.201700499
   Web of Science ®Google Scholar
• Bhattacherjee, D., Sufian, A., Mahato, S. K., Begum, S., Banerjee, K., De, S., Srivastava, H. K., & Bhabak, K. P. (2019). Trisulfides over disulfides: Highly selective synthetic strategies, anti-proliferative activities and sustained H2S release profiles. Chemical Communications (Cambridge, England), 55(90), 13534–13537. https://doi.org/10.1039/c9cc05562b
   PubMed Web of Science ®Google Scholar
• Bzówka, M., Mitusińska, K., Raczyńska, A., Samol, A., Tuszyński, J. A., & Góra, A. (2020). Structural and evolutionary analysis indicate that the Sars-COV-2 Mpro is a challenging target for small-molecule inhibitor design. International Journal of Molecular Sciences, 21(9), 3099-3116. https://doi.org/10.3390/ijms21093099
   Google Scholar
• Cheng, B., & Li, T. (2020). Discovery of alliin as a putative inhibitor of the main protease of SARS-CoV-2 by molecular docking . Biotechniques, 69(2), 108–112. https://doi.org/10.2144/btn-2020-0038
   PubMed Web of Science ®Google Scholar
• Dai, W., Zhang, B., Jiang, X. M., Su, H., Li, J., Zhao, Y., Xie, X., Jin, Z., Peng, J., Liu, F., Li, C., Li, Y., Bai, F., Wang, H., Cheng, X., Cen, X., Hu, S., Yang, X., Wang, J., … Liu, H. (2020). Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease. Science (New York, N.Y.), 368(6497), 1331–1335. ). https://doi.org/10.1126/science.abb4489
   PubMed Web of Science ®Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅log(N) Method for Ewald sums in large systems. Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397
   Web of Science ®Google Scholar
• Dassault Systèmes BIOVIA. (2016). Discovery studio modeling environment, Release 2017. Dassault Systèmes.
   Google Scholar
• Ding, L., Zhang, X. X., Wei, P., Fan, K., & Lai, L. (2005). The interaction between severe acute respiratory syndrome coronavirus 3C-like proteinase and a dimeric inhibitor by capillary electrophoresis. Analytical Biochemistry, 343(1), 159–165. https://doi.org/10.1016/j.ab.2005.04.027
   PubMed Web of Science ®Google Scholar
• Favipiravir, protease inhibitors, oseltamivir -Gpo, hydroxychloroquine for treatment of COVID-19 - Full Text View - ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04303299?cond=protease+inhibitors+covid-19&draw=2
   Google Scholar
• Genheden, S., & Ryde, U. (2015, May 1). The MM/PBSA and MM/GBSA methods to estimate ligand-binding affinities. Expert Opinion on Drug Discovery, 10(5), 449–461. https://doi.org/10.1517/17460441.2015.1032936
   PubMed Web of Science ®Google Scholar
• Ghosh, A. K., Brindisi, M., Shahabi, D., Chapman, M. E., & Mesecar, A. D. (2020). Drug development and medicinal chemistry efforts toward SARS-coronavirus and Covid-19 therapeutics. Chemmedchem, 15(11), 907–932. https://doi.org/10.1002/cmdc.202000223
   PubMed Web of Science ®Google Scholar
• Goyal, B., & Goyal, D. (2020, June 8). Targeting the dimerization of the main protease of coronaviruses: A potential broad-spectrum therapeutic strategy. ACS Combinatorial Science, (6), 297–305. https://doi.org/10.1021/acscombsci.0c00058
   Google Scholar
• Grum-Tokars, V., Ratia, K., Begaye, A., Baker, S. C., & Mesecar, A. D. (2008). Evaluating the 3C-like protease activity of SARS-coronavirus: Recommendations for standardized assays for drug discovery. Virus Research, 133(1), 63–73. https://doi.org/10.1016/j.virusres.2007.02.015
   PubMed Web of Science ®Google Scholar
• Guedes, I. A., Pereira, F. S. S., & Dardenne, L. E. (2018, September 24). Empirical scoring functions for structure-based virtual screening: Applications, critical aspects, and challenges. Frontiers in Pharmacology, 9, 1089. https://doi.org/10.3389/fphar.2018.01089
   PubMed Web of Science ®Google Scholar
• Haug, E. J., Arora, J. S., & Matsui, K. (1976). A steepest-descent method for optimization of mechanical systems. Journal of Optimization Theory and Applications, 19(3), 401–424. https://doi.org/10.1007/BF00941484
   Web of Science ®Google Scholar
• Hess, B., Bekker, H., Berendsen, H. J. C., & Fraaije, J. G. E. M. (1997). LINCS: A linear constraint solver for molecular simulations. Journal of Computational Chemistry, 18(12), 1463–1472. https://doi.org/10.1002/(SICI)1096-987X(199709)18:12 < 1463::AID-JCC4 > 3.0.CO;2-H
   Web of Science ®Google Scholar
• Hsu, W. C., Chang, H. C., Chou, C. Y., Tsai, P. J., Lin, P. I., & Chang, G. G. (2005). Critical assessment of important regions in the subunit association and catalytic action of the severe acute respiratory syndrome coronavirus main protease. Journal of Biological Chemistry, 280(24), 22741–22748. https://doi.org/10.1074/jbc.M502556200
   PubMed Web of Science ®Google Scholar
• Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., Duan, Y., Yu, J., Wang, L., Yang, K., Liu, F., Jiang, R., Yang, X., You, T., Liu, X., … Yang, H. (2020). Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors. Nature, 582(7811), 289–293. https://doi.org/10.1038/s41586-020-2223-y
   PubMed Web of Science ®Google Scholar
• Jin, Z., Zhao, Y., Sun, Y., Zhang, B., Wang, H., Wu, Y., Zhu, Y., Zhu, C., Hu, T., Du, X., Duan, Y., Yu, J., Yang, X., Yang, X., Yang, K., Liu, X., Guddat, L. W., Xiao, G., Zhang, L., Yang, H., & Rao, Z. (2020). Structural basis for the inhibition of SARS-CoV-2 main protease by antineoplastic drug carmofur. Nature Structural & Molecular Biology, 27(6), 529–532. https://doi.org/10.1038/s41594-020-0440-6
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. Journal of Chemical Physics, 79(2), 926–935. https://doi.org/10.1063/1.445869
   Web of Science ®Google Scholar
• Kumalo, H. M., Bhakat, S., & Soliman, M. E. S. (2015). Theory and applications of covalent docking in drug discovery: Merits and pitfalls. Molecules (Basel, Switzerland), 20(2), 1984–2000. February 1, pp. https://doi.org/10.3390/molecules20021984
   PubMed Web of Science ®Google Scholar
• Kumari, R., Kumar, R., & Lynn, A. G. (2014). g_mmpbsa-a GROMACS tool for high-throughput MM-PBSA calculations. Journal of Chemical Information and Modeling, 54(7), 1951–1962. https://doi.org/10.1021/ci500020m
   PubMed Web of Science ®Google Scholar
• Kuo, C.-J., & Liang, P.-H. (2015). Characterization and inhibition of the main protease of severe acute respiratory syndrome coronavirus. ChemBioEng Reviews, 2(2), 118–132. https://doi.org/10.1002/cben.201400031
   Web of Science ®Google Scholar
• Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., Xing, X., Xiang, N., Wu, Y., Li, C., Chen, Q., Li, D., Liu, T., Zhao, J., Liu, M., … Feng, Z. (2020). Early Transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. The New England Journal of Medicine, 382(13), 1199–1207. https://doi.org/10.1056/NEJMoa2001316
   PubMed Web of Science ®Google Scholar
• Li, Z., Li, X., Huang, Y. Y., Wu, Y., Liu, R., Zhou, L., Lin, Y., Wu, D., Zhang, L., Liu, H., Xu, X., Yu, K., Zhang, Y., Cui, J., Zhan, C. G., Wang, X., & Luo, H. B. (2020). Identify potent SARS-CoV-2 main protease inhibitors via accelerated free energy perturbation-based virtual screening of existing drugs. Proceedings of the National Academy of Sciences of the United States of America, 117(44), 27381–27387. https://doi.org/10.1073/pnas.2010470117
   PubMed Web of Science ®Google Scholar
• Lin, P. Y., Chou, C. Y., Chang, H. C., Hsu, W. C., & Chang, G. G. (2008). Correlation between dissociation and catalysis of SARS-CoV main protease. Archives of Biochemistry and Biophysics, 472(1), 34–42. https://doi.org/10.1016/j.abb.2008.01.023
   PubMed Web of Science ®Google Scholar
• Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hu, Z., Zhong, W., & Wang, M. (2020, December 1). Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discovery, 6(1), 16. https://doi.org/10.1038/s41421-020-0156-0
   PubMed Web of Science ®Google Scholar
• Mahato, S. K., Bhattacherjee, D., & Bhabak, K. P. (2020). The biothiol-triggered organotrisulfide-based self-immolative fluorogenic donors of hydrogen sulfide enable lysosomal trafficking. Chemical Communications (Cambridge, England), 56(56), 7769–7772. https://doi.org/10.1039/d0cc00613k
   PubMed Web of Science ®Google Scholar
• Menéndez, C. A., Byléhn, F., Perez-Lemus, G. R., Alvarado, W., & de Pablo, J. J. (2020). Molecular characterization of ebselen binding activity to SARS-CoV-2 main protease. Science Advances, 6(37), eabd0345. https://doi.org/10.1126/sciadv.abd0345
   Google Scholar
• Owen, C. D., Lukacik, P., Strain-Damerell, C. M., Douangamath, A., Powell, A. J., Fearon, D., Brandao-Neto, J., Crawshaw, A. D., Aragao, D., Williams, M., Flaig, R., Hall, D. R., McAuley, K. E., Mazzorana, M., Stuart, D. I., von Delft, F., & Walsh, M. A. (2020). SARS-CoV-2 main protease with unliganded active site (2019-nCoV, coronavirus disease 2019, COVID-19). https://www.rcsb.org/structure/6Y84
   Google Scholar
• Penman, S. L., Kiy, R. T., Jensen, R. L., Beoku-Betts, C., Alfirevic, A., Back, D., Khoo, S. H., Owen, A., Pirmohamed, M., Park, B. K., Meng, X., Goldring, C. E., & Chadwick, A. E. (2020, October 1). Safety perspectives on presently considered drugs for the treatment of COVID-19. British Journal of Pharmacology, 4353–4374. https://doi.org/10.1111/bph.15204.
   Google Scholar
• Pillaiyar, T., Manickam, M., Namasivayam, V., Hayashi, Y., & Jung, S. H. (2016, July 28). An Overview of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) 3CL protease inhibitors: Peptidomimetics and small molecule chemotherapy. Journal of Medicinal Chemistry, 59(14), 6595–6628. https://doi.org/10.1021/acs.jmedchem.5b01461
   PubMed Web of Science ®Google Scholar
• Richardson, P., Griffin, I., Tucker, C., Smith, D., Oechsle, O., Phelan, A., Rawling, M., Savory, E., & Stebbing, J. (2020). Baricitinib as potential treatment for 2019-NCoV acute respiratory disease. The Lancet, 395(10223), e30–e31. February 15, pp. https://doi.org/10.1016/S0140-6736(20)30304-4
   PubMed Web of Science ®Google Scholar
• Rouf, R., Uddin, S. J., Sarker, D. K., Islam, M. T., Ali, E. S., Shilpi, J. A., Nahar, L., Tiralongo, E., & Sarker, S. D. (2020, October 1). Antiviral potential of garlic (allium sativum) and its organosulfur compounds: A systematic update of pre-clinical and clinical data. Trends Food Sci Technol, 104, 219–234. https://doi.org/10.1016/j.tifs.2020.08.006
   PubMed Web of Science ®Google Scholar
• Rut, W., Groborz, K., Zhang, L., Sun, X., Zmudzinski, M., Pawlik, B., Wang, X., Jochmans, D., Neyts, J., Młynarski, W., Hilgenfeld, R., & Drag, M. (2021). SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging. Nature Chemical Biology, 17, 222–228. https://doi.org/10.1038/s41589-020-00689-z
   PubMed Web of Science ®Google Scholar
• Ryu, Y. B., Jeong, H. J., Kim, J. H., Kim, Y. M., Park, J.-Y., Kim, D., Nguyen, T. T. H., Park, S.-J., Chang, J. S., Park, K. H., Rho, M.-C., & Lee, W. S. (2010). Biflavonoids from Torreya Nucifera Displaying SARS-CoV 3CL(pro) inhibition. Bioorganic & Medicinal Chemistry, 18(22), 7940–7947. https://doi.org/10.1016/j.bmc.2010.09.035
   PubMed Web of Science ®Google Scholar
• Scott, K. A., & Njardarson, J. T. (2018, February). Analysis of US FDA-approved drugs containing sulfur atoms. Topics in Current Chemistry (Cham), 376(1), 5. https://doi.org/10.1007/s41061-018-0184-5
   PubMed Web of Science ®Google Scholar
• Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., Montgomery, S. A., Hogg, A., Babusis, D., Clarke, M. O., Spahn, J. E., Bauer, L., Sellers, S., Porter, D., Feng, J. Y., Cihlar, T., Jordan, R., Denison, M. R., & Baric, R. S. (2020). Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV. Nature Communications, 11(1), 222-236. https://doi.org/10.1038/s41467-019-13940-6
   Google Scholar
• Singh, E., Khan, R. J., Jha, R. K., Amera, G. M., Jain, M., Singh, R. P., Muthukumaran, J., & Singh, A. K. (2020, December 1). A comprehensive review on promising anti-viral therapeutic candidates identified against main protease from SARS-CoV-2 through various computational methods. Journal, Genetic Engineering & Biotechnology, 18(1), 69. https://doi.org/10.1186/s43141-020-00085-z
   PubMed Web of Science ®Google Scholar
• Thurakkal, L., Singh, S., Roy, R., Kar, P., Sadhukhan, S., & Porel, M. (2021). An in-silico study on selected organosulfur compounds as potential drugs for SARS-CoV-2 infection via binding multiple drug targets. Chemical Physics Letters, 763, 138193. https://doi.org/10.1016/j.cplett.2020.138193
   PubMed Web of Science ®Google Scholar
• Thuy, B. T. P., My, T. T. A., Hai, N. T. T., Hieu, L. T., Hoa, T. T., Thi Phuong Loan, H., Triet, N. T., Anh, T. T., Van; Quy, P. T., Tat, P., Van; Hue, N., Van; Quang, D. T., Trung, N. T., Tung, V. T., Huynh, L. K., & Nhung, N. T. A. (2020). Investigation into SARS-CoV-2 resistance of compounds in garlic essential oil. ACS Omega, 5(14), 8312–8320. https://doi.org/10.1021/acsomega.0c00772
   PubMed Web of Science ®Google Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (December 2005). GROMACS: Fast, flexible, and free. Journal of Computational Chemistry, 26(16), 1701–1718. pp. https://doi.org/10.1002/jcc.20291
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & Mackerell, A. D. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. https://doi.org/10.1002/jcc.21367
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Raman, E. P., & MacKerell, A. D. (2012). Automation of the CHARMM General Force Field (CGenFF) II: Assignment of bonded parameters and partial atomic charges. Journal of Chemical Information and Modeling, 52(12), 3155–3168. https://doi.org/10.1021/ci3003649
   PubMed Web of Science ®Google Scholar
• Wang, C., Greene, D., Xiao, L., Qi, R., & Luo, R. (2017). Recent developments and applications of the MMPBSA method. Frontiers in Molecular Biosciences, 4, 87. https://doi.org/10.3389/fmolb.2017.00087
   PubMed Web of Science ®Google Scholar
• Wang, E., Sun, H., Wang, J., Wang, Z., Liu, H., Zhang, J. Z. H., & Hou, T. (2019). End-point binding free energy calculation with MM/PBSA and MM/GBSA: Strategies and applications in drug design. Chemical Reviews, 119(16), 9478–9508. https://doi.org/10.1021/acs.chemrev.9b00055
   PubMed Web of Science ®Google Scholar
• Wang, F., Chen, C., Tan, W., Yang, K., & Yang, H. (2016). Structure of main protease from human coronavirus NL63: Insights for wide spectrum anti-coronavirus drug design. Scientific Reports, 6, 22677-22680. https://doi.org/10.1038/srep22677.
   Google Scholar
• Wei, P., Fan, K., Chen, H., Ma, L., Huang, C., Tan, L., Xi, D., Li, C., Liu, Y., Cao, A., & Lai, L. (2006). The N-terminal octapeptide acts as a dimerization inhibitor of SARS coronavirus 3C-like proteinase. Biochemical and Biophysical Research Communications, 339(3), 865–872. https://doi.org/10.1016/j.bbrc.2005.11.102
   PubMed Web of Science ®Google Scholar
• Wu, F., Zhao, S., Yu, B., Chen, Y. M., Wang, W., Song, Z. G., Hu, Y., Tao, Z. W., Tian, J. H., Pei, Y. Y., Yuan, M. L., Zhang, Y. L., Dai, F. H., Liu, Y., Wang, Q. M., Zheng, J. J., Xu, L., Holmes, E. C., & Zhang, Y. Z. (2020). A new coronavirus associated with human respiratory disease in China. Nature, 579(7798), 265–269. https://doi.org/10.1038/s41586-020-2008-3
   PubMed Web of Science ®Google Scholar
• Xu, T., Ooi, A., Lee, H. C., Wilmouth, R., Liu, D. X., & Lescar, J. (2005). Structure of the SARS coronavirus main proteinase as an active C2 crystallographic dimer. Acta Crystallographica Section F, Structural Biology and Crystallization Communications, 61(Pt 11), 964–966. https://doi.org/10.1107/S1744309105033257
   PubMedGoogle Scholar
• Yang, H., Xie, W., Xue, X., Yang, K., Ma, J., Liang, W., Zhao, Q., Zhou, Z., Pei, D., Ziebuhr, J., Hilgenfeld, R., Kwok, Y. Y., Wong, L., Gao, G., Chen, S., Chen, Z., Ma, D., Bartlam, M., & Rao, Z. (2005). Design of wide-spectrum inhibitors targeting coronavirus main proteases. PLoS Biology, 3(10), e324. https://doi.org/10.1371/journal.pbio.0030324
   PubMed Web of Science ®Google Scholar
• Yang, H., Yang, M., Ding, Y., Liu, Y., Lou, Z., Zhou, Z., Sun, L., Mo, L., Ye, S., Pang, H., Gao, G. F., Anand, K., Bartlam, M., Hilgenfeld, R., & Rao, Z. (2003). The crystal structures of severe acute respiratory syndrome virus main protease and its complex with an inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 100(23), 13190–13195. https://doi.org/10.1073/pnas.1835675100
   PubMed Web of Science ®Google Scholar
• Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020). Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors. Science (New York, N.Y.), 368(6489), 409–412. https://doi.org/10.1126/science.abb3405
   PubMed Web of Science ®Google Scholar
• Zhang, X., Perez-Sanchez, H. C., & Lightstone, F. (2017). A comprehensive docking and MM/GBSA rescoring study of ligand recognition upon binding antithrombin. Current Topics in Medicinal Chemistry, 17(14), 1631–1639. https://doi.org/10.2174/1568026616666161117112604
   PubMed Web of Science ®Google Scholar
• Zhao, Q., Li, S., Xue, F., Zou, Y., Chen, C., Bartlam, M., & Rao, Z. (2008). Structure of the main protease from a global infectious human coronavirus, HCoV-HKU1. Journal of Virology, 82(17), 8647–8655. https://doi.org/10.1128/JVI.00298-08
   PubMed Web of Science ®Google Scholar
• Zhou, P., Yang, X., Lou; Wang, X. G., Hu, B., Zhang, L., Zhang, W., Si, H. R., Zhu, Y., Li, B., Huang, C. L., Chen, H. D., Chen, J., Luo, Y., Guo, H., Jiang, R., Di; Liu, M. Q., Chen, Y., Shen, X. R., Wang, X., Zheng, X. S., Zhao, K., … Shi, Z. L. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270–273. https://doi.org/10.1038/s41586-020-2012-7
   PubMed Web of Science ®Google Scholar
• Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., Niu, P., Zhan, F., Ma, X., Wang, D., Xu, W., Wu, G., Gao, G. F., & Tan, W. (2020). A Novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine, 382(8), 727–733. https://doi.org/10.1056/NEJMoa2001017
   PubMed Web of Science ®Google Scholar